Biogen Inc. buy BMO Capital Markets
Start price
09.11.23
/
50%
€211.40
Target price
09.11.24
€276.44
Performance (%)
-23.23%
End price
10.11.24
€162.30
Summary
This prediction ended on 10.11.24 with a price of €162.30. The price of Biogen Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -23.23%. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Biogen Inc. | 4.939% | 4.939% | 28.182% |
| iShares Core DAX® | 1.927% | -2.112% | 11.138% |
| iShares Nasdaq 100 | -0.184% | -5.899% | -0.151% |
| iShares Nikkei 225® | 7.076% | 6.457% | 28.830% |
| iShares S&P 500 | -0.201% | -3.667% | -0.104% |
Comments by BMO_Capital_Markets for this prediction
In the thread Biogen Inc. diskutieren
Biogen Inc. (NASDAQ: BIIB) had its price target lowered by analysts at BMO Capital Markets from $314.00 to $295.00. They now have an "outperform" rating on the stock.
Ratings data for BIIB provided by MarketBeat
In the thread Trading Biogen Inc.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten